Diagnostics Manufacturing During COVID-19


Fully Operational. No expected interruptions to product or service delivery.

SCHOTT MINIFAB is dedicated to maintaining safe, healthy, and productive operations during COVID-19.

As a result of our continuous effort to mitigate the effects of COVID-19 on business operations, we are pleased to confirm that there are no current or future interruptions expected to product or service delivery.


All SCHOTT MINIFAB sites operate under a COVID-Safe plan. Each plan is site-specific and incorporates:

Strict compliance with local government regulations and health orders;

Administrative measures;

Engineering and social distancing measures;

Hygiene and use of PPE;

Staff training, well-being, and communications programs.


SITE STATUS: Scoresby, Victoria, Australia

Our head office and manufacturing facility is fully operational.

Although local government “Stage 4” restrictions have affected some businesses in the region, SCHOTT MINIFAB has been exempted from such restrictions as a manufacturer of medical and pharmaceutical products.

Staff operating in Scoresby work on a mixture of on-site and work from home arrangements depending on their role.

Fully Operational

SITE STATUS: Jena, Germany

Our centre for glass excellence in Jena, Germany, is fully operational.

Staff operating in Jena work on a mixture of on-site and work from home arrangements depending on their role.

Fully Operational

SITE STATUS: San Francisco, USA

Our sales and project support activities in San Francisco, USA, are fully operational via a work-from-home model.

Fully Operational


Further Information: For further information on our COVID-Safe operations, please contact us.

Latest News from Minifab

February 11, 2021

Case Study Webinar: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

in Events
Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. READ MORE
December 08, 2020

SCHOTT MINIFAB - IVD Microfluidics Webinar

in Events
What does it take to create a successful microfluidic diagnostic device? Learn from the world leaders in both glass and polymer. 9am CET 18 December 2020. Limited places so register now. READ MORE
Greg Wolters, CEO of SCHOTT MINIFAB with the 20 Millionth TearLab Osmolarity Test Card prior to shipping.
July 29, 2020

TearLab and SCHOTT MINIFAB Announce '20 Million' Manufacturing Milestone

in News
TearLab® Corporation, together with SCHOTT MINIFAB are celebrating an important milestone with the delivery of the 20 millionth microfluidic eye test card from the production line in Melbourne, Australia. The milestone comes as a result of a 13-year contract manufacturing partnership between the two companies, beginning in 2007 with an ambitious microfluidic product development program. READ MORE
June 22, 2020

Microfluidic product development: Guiding principles to de-risk your development program

in Microfluidics
When it comes to managing and mitigating product development risk, there are six guiding principles that are proven to work. READ MORE

Subscribe for email updates

Stay up to date with the latest news, case studies and annoucements from Minifab.